Dr. Kröger is a research scientist at the Centre d’excellence sur le vieillissement de Québec (CEVQ) du CIUSSSCN and an adjunct professor at the Faculté de pharmacie de l’Université Laval and at the Department of Family Medicine of McGill University. A pharmacist and (pharmaco-) epidemiologist by training, Dr Kröger uses data from epidemiological cohort studies or from administrative data banks for her research. She also performs systematic, scoping or mixed methods knowledge syntheses. For over 10 years, she has been studying risk factors for dementia (Interview with the Australian Broadcasting Corporation, Seafood: mercury and dementia, http://www.abc.net.au/radionational/programs/(healthreport/seafood,-mercury,-and-dementia./7149328, ABC).
Dr. Kröger’s current research program focuses on the medication treatment of seniors affected by dementia. It aims at improving medication use and, more specifically, deprescribing medications of questionable benefit (http://pourvivreensante.com/est-ce-que-je-prends-trop-de-medicaments/). Since 2013, she has been leading intervention and evaluation studies in long-term care facilities to assess whether interdisciplinary knowledge exchange interventions, together with critical medication reviews based on validated criteria, are successful in deprescribing medications of questionable benefit and to decrease residents’ medication load.(« OptimaMed » and « PEPS » studies http://www.ciusss-capitalenationale.gouv.qc.ca/sites/default/files/medication_demence_severe_oct2015.pdf).
Furthermore, Dr. Kröger is an affiliated researcher at the Institut national de santé publique du Québec (INSPQ) where she collaborates in the surveillance of dementia and related diseases in the Quebec population (https://www.inspq.qc.ca/es/node/4223).She is also a member of the Scientific Council of the Institut national d’excellence en santé et en services sociaux (INESSS) and a scientist member of the Ethics Research Board of the CIUSSSCN.
HSS
1050, chemin Sainte-Foy
L2-30
Québec, Québec
Canada G1S 4L8
Latest news
Data not available
- Takponon, CynthiaEmployeecynthia.takponon@crchudequebec.ulaval.ca
Discontinuation of bisphosphonates in seniors: a systematic review on health outcomes
Journal ArticleArch Osteoporos, 16 (1), 2021.
Abstract | Links: 
Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions
Journal ArticleJ Cannabis Res, 3 (1), 2021.
Abstract | Links:
Health Impacts and Characteristics of Deprescribing Interventions in Older Adults: Protocol for a Systematic Review and Meta-analysis
Journal ArticleJMIR Res Protoc, 10 (12), 2021.
Abstract | Links: 
A New Care Model Reduces Polypharmacy and Potentially Inappropriate Medications in Long-Term Care
Journal ArticleJ Am Med Dir Assoc, 22 (1), 2021.
Abstract | Links:
User-centered and theory-based design of a professional training program on shared decision-making with older adults living with neurocognitive disorders: a mixed-methods study
Journal ArticleBMC Med Inform Decis Mak, 21 (1), 2021.
Abstract | Links:
Medical cannabis for chronic pain
Journal ArticleBMJ, 374 , 2021.
| Links:
Professional training on shared decision making with older adults living with neurocognitive disorders: a mixed-methods implementation study
Journal ArticleBMC Med Inform Decis Mak, 20 (1), 2020.
Abstract | Links:
Is Benzodiazepine Use Associated With the Risk of Dementia and Cognitive Impairment-Not Dementia in Older Persons? The Canadian Study of Health and Aging
Journal ArticleAnn Pharmacother, 54 (3), 2020.
Abstract | Links:
Reducing complexity of patient decision aids for community-based older adults with dementia and their caregivers: multiple case study of Decision Boxes
Journal ArticleBMJ Open, 9 (5), 2019.
Abstract | Links:
Exposure to polychlorinated biphenyls and organochlorine pesticides and risk of dementia, Alzheimer's disease and cognitive decline in an older population: a prospective analysis from the Canadian Study of Health and Aging
Journal ArticleEnviron Health, 18 (1), 2019.
Abstract | Links:
Active projects
- La collaboration entre les pharmaciens GMF et communautaires, les médecins de famille et infirmières des GMF pour soutenir l’autonomie des aînés ayant des troubles cognitifs, from 2023-05-01 to 2024-04-30
- La part du traitement de la douleur chronique non ancéreuse d’origine musculosquelettique parmi les indications cliniques de nouvelles ordonnances d’opioïdes au Québec , from 2021-04-01 to 2024-03-31
- La qualité des soins gériatriques à la Clinique de gériatrie de Québec et leurs partenaires de la Société Alzheimer de Québec – Début d’un laboratoire vivant en marge de la COVID, from 2023-04-01 to 2024-03-31
- Phase Two of the Canadian Consortium on Neurodegeneration in Aging, from 2019-04-01 to 2024-03-31
- Projet GPS: Évaluation de l'impact de la réorganisation du travail en Groupe de médecine de famille (GMF) sur la Pharmacothérapie et le Soutien à l'autonomie des personnes âgées ayant un trouble neuro-cognitif majeur, from 2019-04-01 to 2024-03-31
- Traduction et adaptation culturelle pour le Québec d’un questionnaire mesurant l’usage médical du cannabis, from 2022-04-01 to 2024-10-30
Recently finished projects
- Projet de recherche sur les modèles novateurs de milieu de vie des aînés atteints de problèmes cognitifs : similitudes, différences, forces et défis, from 2019-04-01 to 2023-03-31
- Traduction et adaptation culturelle d'un questionnaire pour la mesure de l'utilisation médicale du cannabis dans le contexte québécois dans une perspective d'études prospectives sur les effets du cannabis médical, from 2021-11-17 to 2022-03-31
- Validation du questionnaire d’Auto-repérage pour Vieillir En Santé (AVES) pour permettre aux personnes aînées d’évaluer elles-mêmes leurs risques de perte d'autonomie, from 2021-03-01 to 2023-03-31
- Vers des milieux de travail et des milieux de vie en CHSLD contributifs d'une meilleure santé durable des travailleurs, des résidents et de leurs proches, from 2021-04-30 to 2022-04-30
- Vivre et Vieillir à Québec, from 2021-10-01 to 2022-09-30